Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dihydrocodeine 30mg tablets
0407020G0AAACAC
|
Dihydrocodeine tartrate | Dihydrocodeine tartrate | Central Nervous System | 125,041 |
|
Dihydrocodeine 60mg modified-release tablets
0407020G0AAADAD
|
Dihydrocodeine tartrate | Dihydrocodeine tartrate | Central Nervous System | 27,530 |
|
Dihydrocodeine 120mg modified-release tablets
0407020G0AAAFAF
|
Dihydrocodeine tartrate | Dihydrocodeine tartrate | Central Nervous System | 13,001 |
|
Dihydrocodeine 90mg modified-release tablets
0407020G0AAAEAE
|
Dihydrocodeine tartrate | Dihydrocodeine tartrate | Central Nervous System | 9,963 |
|
Dihydrocodeine 40mg tablets
0407020G0AAAIAI
|
Dihydrocodeine tartrate | Dihydrocodeine tartrate | Central Nervous System | 538 |
|
Dihydrocodeine 10mg/5ml oral suspension
0407020G0AAAPAP
|
Dihydrocodeine tartrate | Dihydrocodeine tartrate | Central Nervous System | 38 |
|
Dihydrocodeine 10mg/5ml oral solution
0407020G0AAAAAA
|
Dihydrocodeine tartrate | Dihydrocodeine tartrate | Central Nervous System | 9 |
|
Dihydrocodeine 15mg/5ml oral solution
0407020G0AAANAN
|
Dihydrocodeine tartrate | Dihydrocodeine tartrate | Central Nervous System | No data available |
|
Dihydrocodeine 30mg/5ml oral solution
0407020G0AAAMAM
|
Dihydrocodeine tartrate | Dihydrocodeine tartrate | Central Nervous System | No data available |
|
Dihydrocodeine 50mg/1ml solution for injection ampoules
0407020G0AAABAB
|
Dihydrocodeine tartrate | Dihydrocodeine tartrate | Central Nervous System | No data available |
|
Dihydrocodeine 60mg/5ml oral liquid
0407020G0AAARAR
|
Dihydrocodeine tartrate | Dihydrocodeine tartrate | Central Nervous System | No data available |
|
Dihydrocodeine 90mg/5ml oral solution
0407020G0AAAKAK
|
Dihydrocodeine tartrate | Dihydrocodeine tartrate | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.